Aditxt, Inc. Restricted Stock Award, Forfeitures, Dividends
Aditxt, Inc. (ADTX) reported Restricted Stock Award, Forfeitures, Dividends of $37.67 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Shareholders' Equity
us-gaap:RestrictedStockAwardForfeituresDividends · last filed 2023-04-17
- Aditxt, Inc. restricted stock award, forfeitures, dividends for fiscal 2022 was $37.67K, a 63.17% decline from fiscal 2021.
- Aditxt, Inc. restricted stock award, forfeitures, dividends for fiscal 2021 was $102.27K.
| Period end | Restricted Stock Award, Forfeitures, Dividends 12 month |
|---|---|
| 2022-12-31 | $37.67K 10-K · filed 2023-04-17 |
| 2021-12-31 | $102.27K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |